Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)

TerminatedOBSERVATIONAL
Enrollment

89

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

November 8, 2017

Study Completion Date

November 8, 2017

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
OTHER

Patient Reported Outcomes

"HRQoL will be assessed using questionnaire EORTC QLQ-C30 and the questionnaire EORTC QLQ-LC 13.~These two questionnaires are validated instruments, translated in various languages and are not used as an intervention but rather to track patient quality of life and symptom reduction in real-life settings. Data for these patient reported outcomes will be collected prospectively from the time of enrolment until the end of follow-up. The two questionnaires will be self-administered by the patients in both cohorts at the enrolment visit and subsequently every 3 months (±1 month) at routine standard of care scheduled visits. The questionnaires are expected to take about 15 minutes to complete"

Trial Locations (110)

Unknown

Research Site, Winnipeg

Research Site, Moncton

Research Site, Halifax

Research Site, Hamilton

Research Site, Kingston

Research Site, London

Research Site, Markham

Research Site, Newmarket

Research Site, Thunder Bay

Research Site, Toronto

Research Site, Montreal

Research Site, Hefei

Research Site, Beijing

Research Site, Guangzhou

Research Site, Harbin

Research Site, Shanghai

Research Site, Xian

Research Site, Chengdu

Research Site, Hangzhou

Research Site, Aix-en-Provence

Research Site, Brest

Research Site, Tours

Research Site, Colmar

Research Site, Rouen

Research Site, Metz-Tessy

Research Site, Limoges

Research Site, Nantes

Research Site, Saint-Nazaire

Research Site, Angers

Research Site, Lorient

Research Site, Saint Priest En Jarez

Research Site, Marseille

Research Site, Bayonne

Research Site, Villefranche-sur-Saône

Research Site, Le Mans

Research Site, Créteil

Research Site, Toulon

Research Site, Brieuc Cedex 1

Research Site, Cannes

Research Site, Chambéry

Research Site, Clermont-Ferrand

Research Site, Gap

Research Site, La Réunion

Research Site, La Rochelle

Research Site, Libourne

Research Site, Mantes-la-Jolie

Research Site, Meaux

Research Site, Montfermeil

Research Site, Mulhouse

Research Site, Orléans

Research Site, Paris

Research Site, Poitiers

Research Site, Rennes

Research Site, Saint-Pierre

Research Site, Saint-Quentin

Research Site, Strasbourg

Research Site, Toulouse

Research Site, Troyes

Research Site, Suresnes

Research Site, Seville

Research Site, Palma de Mallorca

Research Site, Badalona

Research Site, Mataró

Research Site, Sabadell

Research Site, Jerez de la Frontera

Research Site, Las Palmas de Gran Canaria

Research Site, A Coruña

Research Site, Majadahonda

Research Site, Pozuelo de Alarcón

Research Site, Oviedo

Research Site, San Cristóbal de La Laguna

Research Site, Reus

Research Site, Barcelona

Research Site, Burgos

Research Site, Granada

Research Site, Jaén

Research Site, Lugo

Research Site, Madrid

Research Site, Málaga

Research Site, Navarra

Research Site, Pontevedra

Research Site, Seville

Research Site, Zaragoza

Research Site, Taichung

Research Site, Changhua

Research Site, Hsinchu

Research Site, Kaohsiung City

Research Site, Taichung

Research Site, Tainan City

Research Site, Taipei

Research Site, Taoyuan District

Research Site, Whitchurch

Research Site, Hull

Research Site, Brighton

Research Site, Maidstone

Research Site, Metropolitan Borough of Wirral

Research Site, Birmingham

Research Site, Bristol

Research Site, Camberley

Research Site, Glasgow

Research Site, Ipswich

Research Site, Leeds

Research Site, London

Research Site, Manchester

Research Site, Newcastle upon Tyne

Research Site, Nottingham

Research Site, Scunthorpe

Research Site, Sheffield

Research Site, Wolverhampton

Research Site, Worcester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY